DAZAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.062900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.554500E-02
Normal-vs-Stage2
8.455100E-03
Normal-vs-Stage3
1.926240E-02
Normal-vs-Stage4
5.325600E-02
Stage1-vs-Stage2
7.650400E-01
Stage1-vs-Stage3
2.953600E-01
Stage1-vs-Stage4
6.031400E-01
Stage2-vs-Stage3
1.215650E-01
Stage2-vs-Stage4
7.505000E-01
Stage3-vs-Stage4
1.702790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.677600E-03
Normal-vs-AfricanAmerican
1.034570E-01
Normal-vs-Asian
1.552300E-02
Caucasian-vs-AfricanAmerican
6.654400E-01
Caucasian-vs-Asian
3.912000E-01
AfricanAmerican-vs-Asian
4.510000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.643200E-03
Normal-vs-Female
3.421800E-03
Male-vs-Female
2.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.011800E-02
Normal-vs-Age(41-60Yrs)
3.155000E-03
Normal-vs-Age(61-80Yrs)
7.239100E-03
Normal-vs-Age(81-100Yrs)
7.295400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.950630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.230200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.279800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.428470E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.968010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.939200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.598500E-03
Normal-vs-Daily Drinker
1.052270E-02
Normal-vs-Weekly Drinker
2.105500E-02
Normal-vs-Occasional Drinker
1.399550E-02
Normal-vs-Social Drinker
2.984800E-03
Non Drinker-vs-Daily Drinker
7.950800E-01
Non Drinker-vs-Weekly Drinker
8.916200E-01
Non Drinker-vs-Occasional Drinker
4.675400E-01
Non Drinker-vs-Social Drinker
4.632000E-01
Daily Drinker-vs-Weekly Drinker
7.567800E-01
Daily Drinker-vs-Occasional Drinker
6.762200E-01
Daily Drinker-vs-Social Drinker
6.755600E-01
Weekly Drinker-vs-Occasional Drinker
5.132800E-01
Weekly Drinker-vs-Social Drinker
4.989000E-01
Occasional Drinker-vs-Social Drinker
9.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.478370E-01
Normal-vs-Grade 2
5.336600E-01
Normal-vs-Grade 3
5.276000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.594400E-01
Grade 1-vs-Grade 3
6.982000E-01
Grade 1-vs-Grade 4
1.478370E-01
Grade 2-vs-Grade 3
8.581400E-01
Grade 2-vs-Grade 4
5.336600E-01
Grade 3-vs-Grade 4
5.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.462700E-03
Normal-vs-NonDiabetic
2.158900E-03
Diabetic-vs-NonDiabetic
8.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.774200E-04
Normal-vs-NoPancreatitis
3.963500E-03
Pancreatitis-vs-NoPancreatitis
3.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.723000E-03
Normal-vs-N1
9.158000E-03
N0-vs-N1
6.351800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.002400E-02
Normal-vs-TP53-NonMutant
4.239900E-02
TP53-Mutant-vs-TP53-NonMutant
8.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
